Andrew J Elliott
Affiliation: University of Washington
- Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatientsA J Elliott
Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle 98104, USA
Am J Psychiatry 155:367-72. 1998..This study examined whether a selective serotonin reuptake inhibitor (paroxetine) had comparable efficacy but greater tolerability than a tricyclic antidepressant (imipramine) in depressed patients with HIV infection...
- Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodoneA J Elliott
Department of Psychiatry and Behavior Sciences, University of Washington, and the Madison Clinic at Harborview Medical Center, Seattle 98104, USA
J Clin Psychiatry 60:226-31. 1999..Nefazodone appears to be more tolerable than TCAs and similar to SSRIs. This study examined the efficacy and tolerability of nefazodone in an open 12-week trial of HIV-seropositive outpatients with major depressive disorder...
- The effect of changes in depression on health related quality of life (HRQoL) in HIV infectionAndrew J Elliott
University of Washington Department of Psychiatry and Behavior Sciences, Madison Clinic at Harborview Medical Center, Seattle, WA, USA
Gen Hosp Psychiatry 24:43-7. 2002..HRQoL improved in patients regardless of drug or response group and as a function of being in this trial suggesting that medications may not be required to affect HRQoL outcomes and that disease management aspects of care are important...